We recommend you use Internet Explorer 10 or above, Firefox or Google Chrome to visit the site.

Guan-Hua Du

Session: Plenary Lecture 5
Date: May 7th, 2020
Time: 08:30 to 09:20
Venue: 201 Meeting Room 
Language: English


Guanhua Du is a professor of Pharmacology; Former-President of the Chinese Pharmacological Society; Councilor of the Executive Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR), Councilor of the Executive Committee of the Asia Pacific Federation of Pharmacologists (APFP); and Director of National Centre for Pharmaceutical Screening.
Dr. Du got his Ph.D. degree from Peking Union Medical College in 1995, and conducted his postdoctoral research in University of Liege, Belgium from 1995 to 1998. Dr. Du is mainly engaged in drug discovery and development, screening methods and strategy, and drug effect and mechanism research in cerebrovascular and neurodegenerative disease. He originated the national high-throughput drug screening system in China, and provided drug screening services for over 300 million samples for domestic pharmaceutical institutions or enterprises.
In recent 10 years, Dr. Du has published more than 400 papers and more than 30 monographs, and applied for more than 90 patents. He has completed preclinical research of 4 new drugs. He is the Associate Editor of Pharmacology & Therapeutics and more than ten other scientific journals.Guanhua Du is a professor of Pharmacology; Former-President of the Chinese Pharmacological Society; Councilor of the Executive Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR), Councilor of the Executive Committee of the Asia Pacific Federation of Pharmacologists (APFP); and Director of National Centre for Pharmaceutical Screening.
Dr. Du got his Ph.D. degree from Peking Union Medical College in 1995, and conducted his postdoctoral research in University of Liege, Belgium from 1995 to 1998. Dr. Du is mainly engaged in drug discovery and development, screening methods and strategy, and drug effect and mechanism research in cerebrovascular and neurodegenerative disease. He originated the national high-throughput drug screening system in China, and provided drug screening services for over 300 million samples for domestic pharmaceutical institutions or enterprises.
In recent 10 years, Dr. Du has published more than 400 papers and more than 30 monographs, and applied for more than 90 patents. He has completed preclinical research of 4 new drugs. He is the Associate Editor of Pharmacology & Therapeutics and more than ten other scientific journals.